Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gatell

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Blood|November 24, 2001
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapyO Kirk, C Pedersen, A Cozzi-Lepri, et al.
Infection Control and Hospital Epidemiology|June 1, 1995
A cluster of fever and hypotension on a surgical intensive care unit related to the contamination of plasma expanders by cell wall products of Bacillus stearothermophilusA Trilla, C Codina, M Salles, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 29, 2010
[Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy]M T Martín, M Rovira, M Massanes, et al.
HIV Medicine|April 23, 2010
Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adultsR González, P Castro, F García, et al.
HIV Medicine|July 21, 2021
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trialB Torres, A C Guardo, M Squarcia, et al.
AIDS (London, England)|March 1, 1994
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)J W Mulder, D A Cooper, L Mathiesen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infectionM Arnedo-Valero, F Garcia, C Gil, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in SpainN Benito, A Rañó, A Moreno, et al.
Thorax|June 1, 1995
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDSP Fernandez, A Torres, J M Miro, et al.
The European Respiratory Journal|November 1, 1995
Aetiology and prognostic factors of patients with AIDS presenting life-threatening acute respiratory failureA Torres, M El-Ebiary, R Marrades, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Blood|November 24, 2001
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapyO Kirk, C Pedersen, A Cozzi-Lepri, et al.
Infection Control and Hospital Epidemiology|June 1, 1995
A cluster of fever and hypotension on a surgical intensive care unit related to the contamination of plasma expanders by cell wall products of Bacillus stearothermophilusA Trilla, C Codina, M Salles, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 29, 2010
[Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy]M T Martín, M Rovira, M Massanes, et al.
HIV Medicine|April 23, 2010
Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adultsR González, P Castro, F García, et al.
HIV Medicine|July 21, 2021
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trialB Torres, A C Guardo, M Squarcia, et al.
AIDS (London, England)|March 1, 1994
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)J W Mulder, D A Cooper, L Mathiesen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infectionM Arnedo-Valero, F Garcia, C Gil, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in SpainN Benito, A Rañó, A Moreno, et al.
Thorax|June 1, 1995
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDSP Fernandez, A Torres, J M Miro, et al.
The European Respiratory Journal|November 1, 1995
Aetiology and prognostic factors of patients with AIDS presenting life-threatening acute respiratory failureA Torres, M El-Ebiary, R Marrades, et al.
Pageof 18